Physician
Our Lady of the Lake Physician Group LLC
Our Lady of the Lake Physician Group LLC was paid $134.00M by Medicaid between Jan 2018 and Dec 2024, across 348 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoOUR LADY OF THE LAKE PHYSICIAN GROUP LLC
BATON ROUGE, LA 70808
BATON ROUGE, LA 70808
33aNPI1033494943assigned 10/12/2011
33bProvider typeAllergy & Immunology Physician
28Total paid$134.00M
24GClaims4,146,117
24DCodes billed348
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Louisiana
Rank by total paid#1 of 23
Median peer was paid$247K
This provider vs. median543×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 416,349 | $14.19M | |
| 2019 | 497,543 | $17.30M | |
| 2020 | 454,912 | $15.68M | |
| 2021 | 769,147 | $19.72M | |
| 2022 | 645,068 | $21.64M | |
| 2023 | 758,355 | $24.43M | |
| 2024incomplete | 604,743 | $21.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 718,098 | 641,375 | $35.29M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 531,754 | 484,279 | $19.59M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.8% | 92,329 | 87,714 | $7.73M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 42,264 | 39,956 | $5.32M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.9% | 81,999 | 74,740 | $5.17M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 63,657 | 58,940 | $4.90M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.6% | 159,497 | 58,691 | $4.78M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 83,731 | 72,158 | $4.63M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.9% | 83,890 | 37,060 | $3.84M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.7% | 57,114 | 52,981 | $3.64M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 255,627 | 217,203 | $3.16M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 47,153 | 38,996 | $3.12M |
336 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 128,852 | $2.95M |
| 99223 | Prolong inpt eval add15 m | 2.0% | 35,545 | $2.70M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.8% | 31,482 | $2.47M |
| 99203 | Doctor's office visit, new patient (routine) | 1.8% | 49,812 | $2.35M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 32,557 | $2.28M |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.4% | 144,664 | $1.87M |
| 99283 | Emergency room visit (moderate) | 1.3% | 38,343 | $1.72M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 24,368 | $1.38M |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 28,853 | $1.27M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12,635 | $1.19M |
| 99205 | Prolong outpt/office vis | <1% | 11,940 | $1.15M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 144,230 | $636K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 4,435 | $575K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 45,786 | $449K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,750 | $351K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 11,258 | $338K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16,426 | $323K |
| 87428 | <1% | 15,871 | $321K | |
| 92551 | <1% | 43,290 | $321K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 30,055 | $313K |
| 95886 | <1% | 3,557 | $283K | |
| 90474 | <1% | 34,495 | $268K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 6,643 | $263K |
| 20611 | <1% | 5,074 | $257K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 6,991 | $237K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 13,644 | $229K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,741 | $218K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,620 | $213K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 771 | $204K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,021 | $204K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,096 | $201K |
| 93000 | <1% | 28,191 | $186K | |
| 99051 | <1% | 17,187 | $182K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,804 | $176K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 7,508 | $163K |
| 0001A | <1% | 6,498 | $156K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 702 | $152K |
| 0002A | <1% | 5,829 | $146K | |
| 99460 | <1% | 3,885 | $142K | |
| 99220 | <1% | 2,200 | $137K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 591 | $132K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,461 | $131K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,884 | $130K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,858 | $127K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27,796 | $126K |
| 99417 | Prolong home eval add 15m | <1% | 2,434 | $125K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 736 | $123K |
| 95812 | <1% | 1,887 | $111K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,564 | $110K |
| 52000 | <1% | 978 | $103K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 4,053 | $97K |
| 99173 | <1% | 58,266 | $91K | |
| 95911 | <1% | 737 | $91K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 10,787 | $88K |
| 95251 | <1% | 3,978 | $87K | |
| 31622 | <1% | 564 | $87K | |
| 95806 | <1% | 1,892 | $84K | |
| 94010 | <1% | 7,265 | $80K | |
| 99385 | <1% | 1,177 | $67K | |
| 31575 | <1% | 1,144 | $62K | |
| 31231 | <1% | 816 | $60K | |
| 95819 | <1% | 845 | $58K | |
| 76942 | <1% | 694 | $58K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,370 | $54K |
| 90682 | <1% | 1,010 | $49K | |
| 0071A | <1% | 1,377 | $48K | |
| 99221 | <1% | 1,351 | $47K | |
| 90686 | <1% | 64,095 | $46K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,333 | $45K |
| 95816 | <1% | 714 | $44K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 364 | $42K |
| 31624 | <1% | 229 | $41K | |
| 95117 | <1% | 4,959 | $39K | |
| 95910 | <1% | 376 | $37K | |
| 94060 | <1% | 3,109 | $37K | |
| 85018 | <1% | 18,868 | $36K | |
| 0072A | <1% | 913 | $33K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 220 | $32K |
| 17110 | <1% | 601 | $31K | |
| 87807 | <1% | 2,917 | $31K | |
| 94729 | <1% | 3,226 | $31K | |
| 31526 | <1% | 578 | $29K | |
| 92558 | <1% | 10,907 | $28K | |
| 20610 | <1% | 1,004 | $27K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 654 | $25K |
| 97802 | <1% | 1,564 | $25K | |
| 99386 | <1% | 404 | $24K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 130 | $24K |
| 99381 | <1% | 389 | $24K | |
| 92587 | <1% | 2,220 | $23K | |
| 25600 | <1% | 149 | $23K | |
| 94726 | <1% | 2,281 | $23K | |
| 93015 | <1% | 440 | $22K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 327 | $22K |
| 31579 | <1% | 272 | $21K | |
| 31653 | <1% | 62 | $18K | |
| 31627 | <1% | 47 | $18K | |
| 99462 | <1% | 894 | $18K | |
| 46600 | <1% | 471 | $17K | |
| 0004A | <1% | 773 | $17K | |
| 95115 | <1% | 2,480 | $16K | |
| 99177 | <1% | 17,334 | $16K | |
| 93880 | <1% | 250 | $14K | |
| 92557 | <1% | 567 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,394 | $14K |
| 90473 | <1% | 1,393 | $12K | |
| 97803 | <1% | 1,358 | $12K | |
| 95913 | <1% | 66 | $12K | |
| 92550 | <1% | 976 | $11K | |
| 47562 | <1% | 36 | $11K | |
| 69210 | <1% | 551 | $10K | |
| 95782 | <1% | 38 | $10K | |
| 95811 | <1% | 70 | $10K | |
| 95885 | <1% | 186 | $10K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 10,833 | $9K |
| 0003A | <1% | 529 | $9K | |
| 81002 | <1% | 4,838 | $8K | |
| 96127 | <1% | 3,043 | $7K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 71 | $7K |
| 99307 | <1% | 1,507 | $7K | |
| 96139 | <1% | 184 | $7K | |
| 90732 | <1% | 83 | $7K | |
| 31629 | <1% | 62 | $6K | |
| 29085 | <1% | 110 | $6K | |
| 31237 | <1% | 39 | $6K | |
| 20605 | <1% | 213 | $6K | |
| 92567 | <1% | 569 | $6K | |
| 29075 | <1% | 131 | $6K | |
| 95720 | <1% | 45 | $6K | |
| 51798 | <1% | 840 | $6K | |
| 99406 | <1% | 1,137 | $5K | |
| 90715 | <1% | 2,565 | $5K | |
| 90651 | <1% | 14,541 | $5K | |
| 99459 | <1% | 755 | $5K | |
| 99305 | <1% | 295 | $5K | |
| 90837 | Psychotherapy session, about an hour | <1% | 102 | $5K |
| 93922 | <1% | 139 | $5K | |
| 99442 | <1% | 697 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 516 | $4K |
| 11719 | <1% | 1,476 | $4K | |
| 31628 | <1% | 61 | $4K | |
| 96161 | <1% | 1,221 | $4K | |
| 92552 | <1% | 332 | $4K | |
| 11750 | <1% | 34 | $4K | |
| 90656 | <1% | 5,559 | $4K | |
| 55700 | <1% | 26 | $4K | |
| 0124A | <1% | 150 | $4K | |
| 64483 | <1% | 46 | $4K | |
| 0054A | <1% | 146 | $4K | |
| 29125 | <1% | 135 | $3K | |
| 99188 | <1% | 259 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 848 | $3K |
| 11100 | <1% | 85 | $3K | |
| 94727 | <1% | 410 | $3K | |
| 96380 | <1% | 272 | $3K | |
| 99219 | <1% | 75 | $3K | |
| 99383 | <1% | 41 | $3K | |
| 95800 | <1% | 14 | $3K | |
| 95012 | <1% | 348 | $3K | |
| 90620 | <1% | 977 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 178 | $3K |
| 26720 | <1% | 24 | $3K | |
| 96130 | <1% | 103 | $3K | |
| 99421 | <1% | 798 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,595 | $3K |
| 97804 | <1% | 370 | $3K | |
| 97597 | <1% | 142 | $3K | |
| 31654 | <1% | 48 | $3K | |
| 20550 | <1% | 112 | $3K | |
| 99225 | <1% | 320 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,385 | $2K |
| 99497 | <1% | 115 | $2K | |
| 99384 | <1% | 29 | $2K | |
| 90621 | <1% | 1,338 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 45 | $2K |
| 92250 | <1% | 177 | $2K | |
| 95909 | <1% | 28 | $2K | |
| 76536 | <1% | 40 | $2K | |
| 96401 | <1% | 48 | $2K | |
| 99172 | <1% | 78 | $2K | |
| 99224 | <1% | 446 | $2K | |
| 90673 | <1% | 186 | $2K | |
| 99441 | <1% | 516 | $2K | |
| 83655 | <1% | 227 | $2K | |
| 31623 | <1% | 32 | $2K | |
| 90750 | <1% | 14 | $2K | |
| 76882 | <1% | 126 | $2K | |
| 94618 | <1% | 248 | $2K | |
| 82962 | <1% | 1,245 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 408 | $1K |
| 20526 | <1% | 41 | $1K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 38 | $1K |
| 90619 | <1% | 4,258 | $1K | |
| 91300 | <1% | 11,020 | $1K | |
| 96133 | <1% | 21 | $1K | |
| 42830 | <1% | 13 | $1K | |
| 0011A | <1% | 53 | $1K | |
| 91320 | <1% | 46 | $1K | |
| 99226 | <1% | 43 | $1K | |
| 92556 | <1% | 71 | $1K | |
| 0012A | <1% | 51 | $1K | |
| 11721 | <1% | 168 | $950.85 | |
| 90734 | <1% | 4,843 | $906.76 | |
| 93970 | <1% | 13 | $880.42 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 836 | $860.78 |
| 81003 | <1% | 573 | $805.48 | |
| 29065 | <1% | 15 | $795.86 | |
| 47379 | <1% | 17 | $776.80 | |
| 92588 | <1% | 57 | $765.26 | |
| 73562 | <1% | 79 | $754.60 | |
| 96138 | <1% | 71 | $748.20 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 2,546 | $714.04 |
| 96137 | <1% | 29 | $632.84 | |
| 0052A | <1% | 17 | $601.70 | |
| 11900 | <1% | 29 | $597.89 | |
| 73030 | <1% | 51 | $556.24 | |
| 96132 | <1% | 18 | $549.54 | |
| 0051A | <1% | 12 | $541.36 | |
| 93356 | <1% | 38 | $506.19 | |
| 93018 | <1% | 89 | $503.10 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 36 | $499.50 |
| 93296 | <1% | 113 | $480.40 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 48 | $445.33 |
| 90710 | <1% | 4,177 | $428.74 | |
| 90670 | <1% | 45,700 | $410.22 | |
| 93295 | <1% | 18 | $391.50 | |
| 81025 | <1% | 69 | $374.84 | |
| 0031A | <1% | 19 | $359.80 | |
| 29540 | <1% | 13 | $324.25 | |
| 80061 | Lipid panel | <1% | 32 | $308.88 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 647 | $304.64 |
| 90672 | <1% | 1,538 | $229.72 | |
| 99304 | <1% | 12 | $222.10 | |
| 0134A | <1% | 19 | $219.43 | |
| 96136 | <1% | 17 | $219.06 | |
| 92504 | <1% | 1,190 | $209.10 | |
| 93272 | <1% | 13 | $208.01 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 48 | $198.25 |
| 11056 | <1% | 12 | $195.64 | |
| V5008 | Hearing screening | <1% | 191 | $195.44 |
| 0064A | <1% | 13 | $185.40 | |
| 99422 | <1% | 36 | $185.25 | |
| 80305 | <1% | 26 | $179.52 | |
| 99443 | <1% | 71 | $172.22 | |
| 94762 | <1% | 30 | $134.34 | |
| 99491 | Ccm add 20min | <1% | 25 | $123.25 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 82 | $122.37 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 85 | $106.22 |
| S9470 | Nutritional counseling, dietitian visit | <1% | 27 | $95.40 |
| 93289 | <1% | 13 | $88.54 | |
| 90785 | <1% | 54 | $78.52 | |
| 93270 | <1% | 13 | $68.25 | |
| 99254 | <1% | 545 | $64.47 | |
| 98967 | <1% | 79 | $63.00 | |
| S8451 | Splint, prefabricated, wrist or ankle | <1% | 128 | $60.00 |
| 90647 | <1% | 12,475 | $49.10 | |
| 88720 | <1% | 22 | $48.58 | |
| 94664 | <1% | 27 | $29.85 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 16 | $29.70 |
| 98968 | <1% | 14 | $26.50 | |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | <1% | 239 | $24.18 |
| 94760 | <1% | 334 | $19.57 | |
| 98966 | <1% | 16 | $8.00 | |
| 90671 | <1% | 14,636 | $3.26 | |
| G0008 | Administration of influenza virus vaccine | <1% | 339 | $2.73 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 266 | $2.30 |
| 90697 | <1% | 14,243 | $0.82 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 74 | $0.27 |
| 90633 | <1% | 28,574 | $0.23 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 17 | $0.06 |
| 90677 | <1% | 457 | $0.01 | |
| 99072 | 0% | 246,617 | $0.00 | |
| 90685 | 0% | 4,606 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 1,163 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 853 | $0.00 |
| 4040F | 0% | 2,163 | $0.00 | |
| 90713 | 0% | 88 | $0.00 | |
| 90707 | 0% | 1,271 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,667 | $0.00 |
| 90648 | 0% | 650 | $0.00 | |
| 90700 | 0% | 1,737 | $0.00 | |
| 90662 | 0% | 71 | $0.00 | |
| 90681 | 0% | 530 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 2,097 | $0.00 |
| 3046F | 0% | 211 | $0.00 | |
| 3288F | 0% | 2,161 | $0.00 | |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 329 | $0.00 |
| 0518F | 0% | 2,151 | $0.00 | |
| 99354 | 0% | 504 | $0.00 | |
| 1100F | 0% | 986 | $0.00 | |
| 90380 | 0% | 59 | $0.00 | |
| 98960 | 0% | 24 | $0.00 | |
| 96160 | 0% | 18 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 28 | $0.00 |
| 91312 | 0% | 104 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 349 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 20 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 36 | $0.00 |
| 99358 | Prolong nursin fac eval 15m | 0% | 16 | $0.00 |
| 3210F | 0% | 14 | $0.00 | |
| 3725F | 0% | 48 | $0.00 | |
| 91308 | 0% | 16 | $0.00 | |
| 90716 | 0% | 1,328 | $0.00 | |
| 90680 | 0% | 33,308 | $0.00 | |
| 90698 | 0% | 18,678 | $0.00 | |
| 99024 | 0% | 30,907 | $0.00 | |
| 90696 | 0% | 2,190 | $0.00 | |
| 90723 | 0% | 12,193 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 532 | $0.00 |
| 90744 | 0% | 6,356 | $0.00 | |
| 91305 | 0% | 260 | $0.00 | |
| 1220F | 0% | 415 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 39 | $0.00 |
| 90660 | 0% | 344 | $0.00 | |
| 1123F | 0% | 2,163 | $0.00 | |
| 91307 | 0% | 2,663 | $0.00 | |
| 1036F | 0% | 4,412 | $0.00 | |
| 90381 | 0% | 130 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 208 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 2,199 | $0.00 |
| 3011F | 0% | 305 | $0.00 | |
| 3351F | 0% | 236 | $0.00 | |
| 99174 | 0% | 429 | $0.00 | |
| G8708 | Patient not prescribed antibiotic | 0% | 12 | $0.00 |
| 78730 | 0% | 27 | $0.00 | |
| 99252 | 0% | 28 | $0.00 | |
| 91301 | 0% | 61 | $0.00 | |
| G8967 | Fda approved oral anticoagulant is prescribed | 0% | 347 | $0.00 |
| 99318 | 0% | 151 | $0.00 | |
| 1101F | 0% | 1,128 | $0.00 | |
| 99253 | 0% | 46 | $0.00 | |
| 3044F | 0% | 39 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 65 | $0.00 |
| 91303 | 0% | 18 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 50 | $0.00 |
| 99495 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIMBOCKER, JEFFREY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Our Lady of the Lake Physician Group, LLC | Baton Rouge, LA | $425K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.